By Dr. Adiel Tel-Oren
While the medical community appears to be struggling ferociously with
the specter of malignant disease, statistics show that in the last few
decades cancer rates have been steadily increasing. Alarmingly, it is
now estimated that one of three Americans will have had cancer during
his or her lifetime. Should this trend continue, within several years
it is likely that one of every two Americans will have the disease.
Therefore, as an informed individual, you should be concerned about the
high risk of developing cancer even in the absence of family history,
significant exposure to carcinogens, or known presence of cancer genes
in your body.
Naturally, a discussion of the many causes for
the victory and spread of cancer in our population will be appropriate
and interesting, but it should be reserved for a lengthy presentation
elsewhere (come to our free Tuesday lectures, for example...). The main
focus of this article is to provide the reader with valuable diagnostic
information of which most patients and health care practitioners are
unaware. Specifically, I would like to briefly summarize the benefits
of using a laboratory blood test called AMAS (Anti-Malignin Antibody in Serum).
